![Mel Mann, MBA, M. Ed, Patient Advocate on X: "IT'S MY BIRTHDAY AGAIN❗️🎉🎂🎁❤️ In January 1995, as a newly diagnosed 'young adult cancer patient,' at the age of 37, a doctor told Mel Mann, MBA, M. Ed, Patient Advocate on X: "IT'S MY BIRTHDAY AGAIN❗️🎉🎂🎁❤️ In January 1995, as a newly diagnosed 'young adult cancer patient,' at the age of 37, a doctor told](https://pbs.twimg.com/media/FtgoFGbWwAEjGA1.jpg:large)
Mel Mann, MBA, M. Ed, Patient Advocate on X: "IT'S MY BIRTHDAY AGAIN❗️🎉🎂🎁❤️ In January 1995, as a newly diagnosed 'young adult cancer patient,' at the age of 37, a doctor told
![Evaluation of imatinib mesylate in the treatment of pulmonary arterial hypertension | Future Cardiology Evaluation of imatinib mesylate in the treatment of pulmonary arterial hypertension | Future Cardiology](https://www.futuremedicine.com/cms/10.2217/fca.09.54/asset/images/medium/graphic1.gif)
Evaluation of imatinib mesylate in the treatment of pulmonary arterial hypertension | Future Cardiology
![Single cell and AI team up to find biomarkers for targeted therapy response in chronic myeloid leukemia - 10x Genomics Single cell and AI team up to find biomarkers for targeted therapy response in chronic myeloid leukemia - 10x Genomics](https://cdn.10xgenomics.com/image/upload/dpr_2.0,e_sharpen,f_auto,q_auto/v1691507785/blog/Hypolobated_small_megakaryocyte.jpg)
Single cell and AI team up to find biomarkers for targeted therapy response in chronic myeloid leukemia - 10x Genomics
![Evaluation of imatinib mesylate in the treatment of pulmonary arterial hypertension | Future Cardiology Evaluation of imatinib mesylate in the treatment of pulmonary arterial hypertension | Future Cardiology](https://www.futuremedicine.com/cms/10.2217/fca.09.54/asset/images/medium/graphic4.gif)